Rockefellers AIDS Part 1 Pfizer
There is plenty of evidence to suggest AIDS was requested, created and distributed by Rockefeller-linked individuals and organizations. For example, there is the "Department of Defense Appropriations Hearings for 1970" - a 1969 document outlining how the National Academy of Sciences-National Research Council advised the US military to develop "synthetic biological agents" with no cure - viruses descriptively and functionally identical to HIV/AIDS. (149) The NAS-NRC was headed by Frederick Seitz at the time - also then President of Rockefeller University. (150)
The real smoking gun is the 1977 Pfizer contract for "Large-Scale Tissue Culture Virus Production for Cancer Research." It's hard to imagine what they meant by "large-scale," as Pfizer was already making "over 28,000 liters of virus harvest fluids" - a mix of viruses now linked to the AIDS virus. (151) Pfizer's head at the time was Edmund T. Pratt, director of Rockefeller's Chase Manhattan Bank and member of Rockefeller's Council on Foreign Relations. (152)
Pfizer's partner in this project was Rockefeller's International Agency for Research in Cancer - the IARC. (153) Pfizer has offices in New York City, and the IARC has offices in Uganda. AIDS first sprung up in NYC and Uganda at about the same time. (154) Another Pfizer director linked to Rockefeller's cancer industry is Paul A. Marks, chief officer at Sloan Kettering Memorial Cancer Center, director of treatment regimens at the National Cancer Institute (NCI) and director of the American Association for Cancer Research. (155)